Assistive Technologies to Address Capabilities of People with Dementia: From Research to Practice.

assessment assistive technologies capabilities dementia economics empowerment ethics human rights psychosocial model of disability public policies

Journal

Dementia (London, England)
ISSN: 1741-2684
Titre abrégé: Dementia (London)
Pays: England
ID NLM: 101128698

Informations de publication

Date de publication:
May 2019
Historique:
pubmed: 13 7 2017
medline: 27 11 2019
entrez: 13 7 2017
Statut: ppublish

Résumé

Assistive technologies became pervasive and virtually present in all our life domains. They can be either an enabler or an obstacle leading to social exclusion. The Fondation Médéric Alzheimer gathered international experts of dementia care, with backgrounds in biomedical, human and social sciences, to analyze how assistive technologies can address the capabilities of people with dementia, on the basis of their needs. Discussion covered the unmet needs of people with dementia, the domains of daily life activities where assistive technologies can provide help to people with dementia, the enabling and empowering impact of technology to improve their safety and wellbeing, barriers and limits of use, technology assessment, ethical and legal issues. The capability approach (possible freedom) appears particularly relevant in person-centered dementia care and technology development. The focus is not on the solution, rather on what the person can do with it: seeing dementia as disability, with technology as an enabler to promote capabilities of the person, provides a useful framework for both research and practice. This article summarizes how these concepts took momentum in professional practice and public policies in the past 15 years (2000-2015), discusses current issues in the design, development and economic model of assistive technologies for people with dementia, and covers how these technologies are being used and assessed.

Identifiants

pubmed: 28699364
doi: 10.1177/1471301217714093
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1568-1595

Auteurs

Paul-Ariel Kenigsberg (PA)

Fondation Médéric Alzheimer, Paris, France.

Jean-Pierre Aquino (JP)

Fondation Médéric Alzheimer, Paris, France.

Alain Bérard (A)

Fondation Médéric Alzheimer, Paris, France.

François Brémond (F)

CoBTeK Lab & INRIA STARS, Université Côte-d'Azur, Nice, France.

Kevin Charras (K)

Fondation Médéric Alzheimer, Paris, France.

Tom Dening (T)

Institute of Mental Health, University of Nottingham, UK.

Rose-Marie Droës (RM)

Department of Psychiatry, VU University Medical Center, Amsterdam, The Netherlands.

Fabrice Gzil (F)

Fondation Médéric Alzheimer, Paris, France.

Ben Hicks (B)

Bournemouth University Dementia Institute, UK.

Anthea Innes (A)

Salford Institute for Dementia University of Salford, Salford, United Kingdom.

Sao-Mai Nguyen (SM)

Lab-STICC, Institut Mines-Télécom Bretagne, Brest, France.

Louise Nygård (L)

Department of Neurobiology, Care sciences and Society, Karolinska Institute, Stockholm, Sweden.

Maribel Pino (M)

Laboratoire Lusage, Hôpital Broca, Assistance publique-Hôpitaux de Paris, France.

Guillaume Sacco (G)

Centre Mémoire de Ressources et de Recherche, CHU de Nice; Université Côte-d'Azur, CoBTeK, Nice, France.

Eric Salmon (E)

Department of Neurology, Liège University Hospital, Belgium.

Henriëtte van der Roest (H)

Department of General Practice and Elderly Care Medicine, Amsterdaù Public Health Research Institute, VU University Medical Center, Amsterdam, The Netherlands.

Hervé Villet (H)

Fondation Médéric Alzheimer, Paris, France.

Marion Villez (M)

Laboratoire LIRTES, Université Paris-Est-Val de Marne, Créteil, France.

Philippe Robert (P)

Université Côte-d'Azur, CoBTeK, & Innovation Alzheimer Association, Nice, France.

Valeria Manera (V)

Université Côte-d'Azur, INRIA STARS & CoBTeK, Nice, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH